Answers are grounded in this paper and cite their sources.
The activation of Ph(2)HSiSiHPh(2) and Me(3)SiSiMe(3) at [Pt(PEt(3))(3)] (1) yielded the products of oxidative addition. The formation of [Pt(SiHPh(2))(2)(PEt(3))(2)] (2) as a mixture of the cis and trans isomers appears to proceed quantitatively, whereas a conversion to give cis-[Pt(SiMe(3))(2)(PEt(3))(2)] (3) was not complete. Treatment of 1 with one equivalent of H(2)SiPh(2) led to cis-and trans-[Pt(H)(SiHPh(2))(PEt(3))(2)] (cis-4, trans-4) together with the dinuclear complex [(Et(3)P)(2)(H)Pt(μ-SiPh(2))(μ-η(2)-HSiPh(2))Pt(PEt(3))] (5). In contrast, HSiMe(3) reacts with [Pt(PEt(3))(3)] to yield cis-[Pt(H)(SiMe(3))(PEt(3))(2)] (7) exclusively. Catalytic reactions of dihydrogen with the disilanes Ph(2)HSiSiHPh(2) or Me(3)SiSiMe(3) in the presence of catalytic amounts of [Pt(PEt(3))(3)] (1) led to the products of hydrogenolysis, H(2)SiPh(2) and HSiMe(3). The conversion of Me(3)SiSiMe(3) is much slower and needs higher temperature to proceed.
No takes yet. Share an insight, caveat, or question.
Voigt et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: